Cargando…

Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay

BACKGROUND: The NeoAzure study has demonstrated that the use of the bisphosphonate zoledronic acid (Zol) in the neoadjuvant setting increases the rate of complete response in primary breast cancer and therefore indicates direct antitumor activity. The purpose of this study was to compare the antitum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fehm, Tanja, Zwirner, Manfred, Wallwiener, Diethelm, Seeger, Harald, Neubauer, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416722/ https://www.ncbi.nlm.nih.gov/pubmed/22824103 http://dx.doi.org/10.1186/1471-2407-12-308

Ejemplares similares

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
por: Fehm, Tanja, et al.
Publicado: (2008)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
por: Banys, Malgorzata, et al.
Publicado: (2013)

The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
por: Hartkopf, Andreas Daniel, et al.
Publicado: (2013)

Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer
por: Fehm, Tanja, et al.
Publicado: (2006)

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
por: Fehm, Tanja, et al.
Publicado: (2007)

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2016)

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
por: Fehm, Tanja, et al.
Publicado: (2009)

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2008)

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2009)

Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay
por: Knight, Louise A, et al.
Publicado: (2009)

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
por: Lengerke, Claudia, et al.
Publicado: (2011)

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
por: Sharma, Sanjay, et al.
Publicado: (2003)

Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers
por: Taran, Florin-Andrei, et al.
Publicado: (2018)

Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
por: Riganti, Chiara, et al.
Publicado: (2013)

Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers
por: Schultz, Silke, et al.
Publicado: (2018)

Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification
por: Wallwiener, Markus, et al.
Publicado: (2012)

Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients
por: Hartkopf, Andreas D., et al.
Publicado: (2016)

Retraction: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
Publicado: (2020)

Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients
por: Hoffmann, Jürgen, et al.
Publicado: (2009)

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
por: Willibald, Marina, et al.
Publicado: (2017)

The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service
por: Wallwiener, Markus, et al.
Publicado: (2010)

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction
por: Yamakawa, Yasuaki, et al.
Publicado: (2017)

PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
por: Li, Yuan, et al.
Publicado: (2018)

Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Chick Embryo Assay as Chemosensitivity Test for Malignant Glioma
por: Shoin, Katsuo, et al.
Publicado: (1991)

Update Breast Cancer 2017 – Implementation of Novel Therapies
por: Lux, Michael P., et al.
Publicado: (2017)

Comparison of assays used for in vitro chemosensitivity testing of human tumours.
por: Salmon, S. E., et al.
Publicado: (1984)

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma
por: Kim, Dae Won, et al.
Publicado: (2023)

Lipid-soluble polyphenols from sweet potato exert antitumor activity and enhance chemosensitivity in breast cancer
por: Kato, Kazuhiro, et al.
Publicado: (2021)

Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis
por: Lai, Yu-Hsuan, et al.
Publicado: (2018)

Update Breast Cancer 2018 (Part 2) – Advanced Breast Cancer, Quality of Life and Prevention
por: Schneeweiss, Andreas, et al.
Publicado: (2018)

Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
por: Chebouti, Issam, et al.
Publicado: (2016)

Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016)

Magnetic resonance imaging findings of high-grade ductal carcinoma in situ of the male breast: A case report
por: Reinhardt, Florian, et al.
Publicado: (2018)

Identifying Mitotic Kinesins as Potential Prognostic Biomarkers in Ovarian Cancer Using Bioinformatic Analyses
por: Liu, Hailun, et al.
Publicado: (2022)

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling
por: Bullinger, Dino, et al.
Publicado: (2007)

Chemosensitivity testing of small cell lung cancer using the MTT assay.
por: Campling, B. G., et al.
Publicado: (1991)

A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy.
por: Wilson, J. K., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_75rplk05ifkt89ai41sj6b13se